https://european-biotechnology.net/wp-content/uploads/2025/03/SpliceBio-1030x465-1.jpg
465
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-14 09:32:332025-03-14 09:32:33SpliceBio lauches Phase I/II study on dual-AAV-based therapy for Stargardt Disease
https://european-biotechnology.net/wp-content/uploads/2025/03/FSA-1030x719-1.jpeg
719
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-12 11:50:152025-03-12 11:50:15Regulatory sandbox will speed up safety assessment of cell-based food
https://european-biotechnology.net/wp-content/uploads/2025/03/1000_F_1033449356_saD0ccutRtdFMXmfjDrcG2LSXgAG18TI.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-12 08:43:192025-03-12 08:43:19Roche inks US$1.65bn obesity deal with Zealand Pharma
https://european-biotechnology.net/wp-content/uploads/2025/03/Novo-Logo.jpg
562
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-10 20:21:492025-03-10 20:21:49Novo Nordisk’s obesity drug CagriSema disappoints again
https://european-biotechnology.net/wp-content/uploads/2025/03/Roche-xpandomer-synthesis-4x-1030x266-1.png
266
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-04 10:55:442025-03-04 10:55:44Roche unveils completely new sequencing approach
https://european-biotechnology.net/wp-content/uploads/2025/03/Hummingbird-2.png
944
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-03-04 09:30:182025-03-04 09:30:18ADC maker Callio Therapeutics secures US$187m in Series A round
https://european-biotechnology.net/wp-content/uploads/2025/02/Cean-industrial-deal-press-conference-26-feb-2025-e1740653248529-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-27 10:49:112025-02-27 10:49:11EU Commission presents Clean Industrial Deal
https://european-biotechnology.net/wp-content/uploads/2025/02/fuse-vectors-20250226-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-26 08:39:072025-02-26 08:39:07Gene therapy manufacturing: Fuse Vectors secures US$5.2m
https://european-biotechnology.net/wp-content/uploads/2025/02/Ryvu-Therapeutics-headquarters-1030x559-1.png
559
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-25 13:56:262025-02-25 13:56:26Ryvu Therapeutics extends cashflow to consolidate pipeline
https://european-biotechnology.net/wp-content/uploads/2025/02/Friedrich-Merz-1030x484-1.jpg
484
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-02-24 10:15:282025-02-24 10:15:28New German Chancellor wants a strong Europe
Scroll to top
